1.
Akbari ME, Rafiee M, Khoei MA, Eshrati B, Hatami H. Incidence and survival of cancers
in the elderly population in Iran: 2001-2005. Asian Pac J Cancer Prev. 2011;12(11):3035-9.
2.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics.
CA: a cancer journal for clinicians. 2011;61(2):69-90.
3.
Alwan A. Global status report on noncommunicable diseases 2010: World Health Organization;
2011.
4.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide
burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer. 2010;127(12):2893-917.
5.
Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence
and mortality in Iran. Annals of oncology. 2008;20(3):556-63.
6.
Kelsen D. Principles and practice of gastrointestinal oncology: Lippincott Williams
& Wilkins; 2008.
7.
Dunlop M. Screening for large bowel neoplasms in individuals with a family history
of colorectal cancer. British journal of surgery. 1992;79(6):488-94.
8.
Parkin DM. Global cancer statistics in the year 2000. The lancet oncology. 2001;2(9):533-43.
9.
Schottenfeld D, Winawer S. Cancers of the large intestine. Cancer Epidemiology and
Prevention. New York: Oxford University Press; 1996.
10.
Parkin DM, Bray F, Devesa S. Cancer burden in the year 2000. The global picture. European
journal of cancer. 2001;37:4-66.
11.
Parkin D, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major
cancers in 1985. International journal of cancer. 1993;54(4):594-606.
12.
Parkin D, Whelan S, Ferlay J, Teppo L, Thomas D. Cancer incidence in five continents
Vol. VIII. IARC scientific publications. 2002;155.
13.
Stewart B, Wild CP. World cancer report 2014. Health. 2017.
14.
Bülow S. Colorectal cancer in patients less than 40 years of age in Denmark, 1943–1967.
Diseases of the Colon & Rectum. 1980;23(5):327-36.
15.
Griffin PM, Liff JM, Greenberg RS, Clark WS. Adenocarcinomas of the colon and rectum
in persons under 40 years old: a population-based study. Gastroenterology. 1991;100(4):1033-40.
16.
MacGillivray D, Swartz S, Robinson A, Cruess D, Smith L. Adenocarcinoma of the colon
and rectum in patients less than 40 years of age. Surgery, gynecology & obstetrics.
1991;172(1):1-7.
17.
Guillem JG, Puig-La Calle J, Cellini C, Murray M, Ng J, Fazzari M, et al. Varying
features of early age-of-onset “sporadic” and hereditary nonpolyposis colorectal cancer
patients. Diseases of the colon & rectum. 1999;42(1):36-42.
18.
Mitry E, Benhamiche A-M, Jouve J-L, Clinard F, Finn-Faivre C, Faivre J. Colorectal
adenocarcinoma in patients under 45 years of age: comparison with older patients in
a well-defined French population. Diseases of the colon & rectum. 2001;44(3):380-7.
19.
Isbister WH. Colorectal cancer below age 40 in the Kingdom of Saudi Arabia. ANZ Journal
of Surgery. 1992;62(6):468-72.
20.
Al-Jaberi TM, Ammari F, Gharieybeh K, Khammash M, Yaghan RJ, Heis H, et al. Colorectal
adenocarcinoma in a defined Jordanian population from 1990 to 1995. Diseases of the
colon & rectum. 1997;40(9):1089-94.
21.
Soliman AS, Bondy ML, Levin B, Hamza MR, Ismail K, Ismail S, et al. Colorectal cancer
in Egyptian patients under 40 years of age. International journal of cancer. 1997;71(1):26-30.
22.
Taghavi A, Fazeli Z, Vahedi M, Baghestani AR, Pourhoseingholi A, Barzegar F, et al.
Increased trend of breast cancer mortality in Iran. Asian Pacific Journal of Cancer
Prevention. 2012;13(1):367-70.
23.
Moradpour F, Fatemi Z. Estimation of the projections of the incidence rates, mortality
and prevalence due to common cancer site in Isfahan, Iran. Asian Pac J Cancer Prev.
2013;14(6):3581-5.
24.
Lawlor D, Wills A, Fraser A, Sayers A, Fraser W. Investment in cancer studies in countries
of low and middle income. Lancet Oncol. 2013;14:e239-48.
25.
Sharp L, Deady S, Gallagher P, Molcho M, Pearce A, Thomas AA, et al. The magnitude
and characteristics of the population of cancer survivors: using population-based
estimates of cancer prevalence to inform service planning for survivorship care. BMC
cancer. 2014;14(1):767.
26.
Takiar R, Krishnan SK, Shah VP. A model approach to calculate cancer prevalence from
5 years survival data for selected cancer sites in India—part II. Asian Pac J Cancer
Prev APJCP. 2014;15(14):5681-4.
27.
Hadji M, Nahvijou A, Seddighi Z, Beiki O, Mohagheghi MA, Mosavi-Jarrahi A, et al.
Challenges to promoting population-based cancer registration in iran: a workshop report.
Asian Pac J Cancer Prev. 2013;14(10):6189-93.
28.
Maracy MR, Moradpour F, Hosseini SM, Tirani M. Cancer incidence and prevalence in
isfahan: application of mortality data to estimates and projects for the period 2001-2015.
International journal of preventive medicine. 2012;3(12):867.
29.
Rashidian H, Daroudi R, Ghiasvand R, Harirchi I, Zendehdel K. Prevalence and Incidence
of premenopausal and postmenopausal breast cancer in Iran in 2010. Basic & Clinical
Cancer Research. 2013;5(3):2-10.
30.
Hassanzade J. Incidence and mortality rate of common gastrointestinal cancers in south
of Iran, a population based study. Iranian journal of cancer prevention. 2011;4(4):163.
31.
Abdifard E, Ghaderi S, Hosseini S, Heidari M. Incidence trends of colorectal cancer
in the West of Iran during 2000-2005. Asian Pac J Cancer Prev. 2013;14(3):1807-11.
32.
Najafi F, Mozaffari H, Karami M, Izadi B, Tavvafzadeh R, Pasdar Y. Trends in incidence
of gastrointestinal tract cancers in Western Iran, 1993-2007. Iranian Red Crescent
Medical Journal. 2011;13(11):805.
33.
Pourhoseingholi MA, Fazeli Z, Ashtari S, Bavand-Pour FSF. Mortality trends of gastrointestinal
cancers in Iranian population. Gastroenterology and hepatology from bed to bench.
2013;6(Suppl 1):S52.
34.
Masoompour SM, Yarmohammadi H, Rezaianzadeh A, Lankarani KB. Cancer incidence in southern
Iran, 1998–2002: Results of population-based cancer registry. Cancer epidemiology.
2011;35(5):e42-e7.
35.
Vardanjani HM, Baneshi MR, Haghdoost A. Total and partial prevalence of cancer across
Kerman Province, Iran, in 2014, using an adapted generalized Network scale-up method.
Asian Pac J Cancer Prev. 2015;16(13):5493-8.
36.
Esna-Ashari F, Sohrabi M, Abadi A, Mehrabian A, Kolahi A, Yavari P, et al. Colorectal
cancer prevalence according to survival data in Iran in 2007. Research in Medicine.
2008;32(3):221-5.
37.
Vardanjani HM, Haghdoost A, Bagheri-Lankarani K, Hadipour M. Estimation and Projection
of Prevalence of Colorectal Cancer in Iran, 2015–2020. Advanced biomedical research.
2018;7.
38.
Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting
cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and
pancreas cancers in the United States. Cancer research. 2014.
39.
Gelband H, Sankaranarayanan R, Gauvreau CL, Horton S, Anderson BO, Bray F, et al.
Costs, affordability, and feasibility of an essential package of cancer control interventions
in low-income and middle-income countries: key messages from Disease Control Priorities.
The Lancet. 2016;387(10033):2133-44.
40.
Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27
sites in the adult population in 2008. International journal of cancer. 2013;132(5):1133-45.
41.
Crooke H, Kobayashi M, Mitchell B, Nwokeji E, Laurie M, Kamble S, et al. Estimating
1-and 5-year relative survival trends in colorectal cancer (CRC) in the United States:
2004 to 2014. American Society of Clinical Oncology; 2018.
42.
Pisani P, Bray F, Parkin DM. Estimates of the world‐wide prevalence of cancer for
25 sites in the adult population. International journal of cancer. 2002;97(1):72-81.
43.
Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of
cancer recurrence in adult cancer survivors: a systematic review of quantitative studies.
Journal of Cancer Survivorship. 2013;7(3):300-22.
44.
Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P. Depression and anxiety in long-term
cancer survivors compared with spouses and healthy controls: a systematic review and
meta-analysis. The lancet oncology. 2013;14(8):721-32.
45.
Rock CL, Doyle C, Demark‐Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, et
al. Nutrition and physical activity guidelines for cancer survivors. CA: a cancer
journal for clinicians. 2012;62(4):242-74.
46.
Tsunoda A, Nakao K, Hiratsuka K, Yasuda N, Shibusawa M, Kusano M. Anxiety, depression
and quality of life in colorectal cancer patients. International journal of clinical
oncology. 2005;10(6):411-7.
47.
Earle CC, Chretien Y, Morris C, Ayanian JZ, Keating NL, Polgreen LA, et al. Employment
among survivors of lung cancer and colorectal cancer. Journal of clinical oncology
: official journal of the American Society of Clinical Oncology. 2010;28(10):1700-5.
48.
Fazeli MS, Adel MG, Lebaschi AH. Colorectal carcinoma: a retrospective, descriptive
study of age, gender, subsite, stage, and differentiation in Iran from 1995 to 2001
as observed in Tehran University. Diseases of the colon & rectum. 2007;50(7):990-5.
49.
El‐Shami K, Oeffinger KC, Erb NL, Willis A, Bretsch JK, Pratt‐Chapman ML, et al. American
Cancer Society colorectal cancer survivorship care guidelines. CA: a cancer journal
for clinicians. 2015;65(6):427-55.